Michael P. Flaherty, M.D., Ph.D., FSCAI, FACC

Michael P. Flaherty, M.D., Ph.D., FSCAI, FACC

Michael P. Flaherty M.D., Ph.D.

Michael P. Flaherty M.D., Ph.D., FSCAI, FACC

  • Assistant Professor of Medicine, Physiology and Biophysics
  • Director, Adult Structural Interventional Program
  • Director of Research, Interventional Cardiology Program
UofL Physicians Outpatient Center
401 East Chestnut Street, Ste. 310
Louisville, KY 40202

502-852-7959 - Academic Office
502-588-4600 - Patient Appointments

Clinical Expertise
Interventional Cardiology; High-Risk PCI; Percutaneous Adult Cardiac Structural Interventions; Stem Cell Therapies for Cardiac Regeneration; Heart Failure


Board Certifications

  • American Board of Internal Medicine -
    Internal Medicine / Cardiovascular Disease / Interventional Cardiology

Education and Training

  • Medical School: University of Louisville
  • Residency: Boston Medical Center
  • Fellowship: University of Louisville (Cardiology); Johns Hopkins University (Interventional Cardiology)


Recent Publications

      • Flaherty MP, Grubb KJ. Transcatheter Aortic Valve Replacement: Focus on Sex-Related Differences in Outcomes. Am J Cardiovasc Drugs. 2015 Mar 10. [Epub ahead of print] PubMed PMID: 25752476.
      • Flaherty MP, Mohsen A, Moore JB, Bartoli CR, Schneibel E, Rawasia W, Williams  ML, Grubb KJ, Hirsch GA. Predictors and clinical impact of pre-existing and acquired thrombocytopenia following transcatheter aortic valve replacement. Catheter Cardiovasc Interv. 2015 Jan 1;85(1):118-29. doi: 10.1002/ccd.25668. Epub 2014 Sep 30. PubMed PMID: 25204308.
      • Bolli R, Birks E, Flaherty MP, Keith M, Ghafghazi S. Response to letter regarding article, "Cell therapy for heart failure: a comprehensive overview of experimental and clinical studies, current challenges, and future directions". Circ Res. 2014 Nov 7;115(11):e33-4. doi: 10.1161/CIRCRESAHA.114.305263. PubMed PMID: 25378533.
      • Leucker TM, Williams ML, Flaherty MP. Transcatheter aortic valve replacement: a novel abdominal transaortic approach. Catheter Cardiovasc Interv. 2014 Mar 1;83(4):670-5. doi: 10.1002/ccd.25252. Epub 2013 Dec 4. PubMed PMID: 24130126.
      • Bartoli CR, McCants KC, Birks EJ, Flaherty MP, Slaughter MS. Percutaneous closure of a patent foramen ovale to prevent paradoxical thromboembolism in a patient with a continuous-flow LVAD. J Invasive Cardiol. 2013 Mar;25(3):154-6. PubMed PMID: 23468448.
      • Guo Y, Flaherty MP, Wu WJ, Tan W, Zhu X, Li Q, Bolli R. Genetic background, gender, age, body temperature, and arterial blood pH have a major impact on myocardial infarct size in the mouse and need to be carefully measured and/or taken into account: results of a comprehensive analysis of determinants of infarct size in 1,074 mice. Basic Res Cardiol. 2012 Sep;107(5):288. doi: 10.1007/s00395-012-0288-y. Epub 2012 Aug 3. PubMed PMID: 22864681; PubMed Central PMCID: PMC3777390.
      • Sayfo S, Stepp LO, Ganzel B, Slaughter MS, Flaherty MP. Management of recurrent leaks following postinfarction ventricular septal defect repairs. J Card Surg. 2012 Sep;27(5):576-80. doi: 10.1111/j.1540-8191.2012.01493.x. Epub 2012 Aug 13. Review. PubMed PMID: 22882412.
      • Flaherty MP, Kamerzell TJ, Dawn B. Wnt signaling and cardiac differentiation. Prog Mol Biol Transl Sci. 2012;111:153-74. doi: 10.1016/B978-0-12-398459-3.00007-1. Review. PubMed PMID: 22917230.
      • Flaherty MP, Johnston PV, Rade JJ. Subacute stent thrombosis owing to complete clopidogrel resistance successfully managed with prasugrel. J Invasive Cardiol. 2011 Jul;23(7):300-4. PubMed PMID: 21725128.
      • Dawn B, Abdel-Latif A, Sanganalmath SK, Flaherty MP, Zuba-Surma EK. Cardiac repair with adult bone marrow-derived cells: the clinical evidence. Antioxid Redox Signal. 2009 Aug;11(8):1865-82. doi: 10.1089/ARS.2009.2462. Review. PubMed PMID: 19203221; PubMed Central PMCID: PMC2848520.